Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Diluted EPS of $0.14 per share (loss) for fiscal year 2025.
LEXICON PHARMACEUTICALS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.14 | +77.8% |
| 2024 | -$0.63 | +21.3% |
| 2023 | -$0.80 | -29.0% |
| 2022 | -$0.62 | -3.3% |
| 2021 | -$0.60 | -13.2% |
| 2020 | -$0.53 | -145.7% |
| 2019 | $1.16 | +201.8% |
| 2018 | -$1.14 | +2.6% |
| 2017 | -$1.17 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.04 | +77.8% | -500.0% |
| June 30, 2025 | $0.01 | +105.9% | +114.3% |
| March 31, 2025 | -$0.07 | +65.0% | +61.1% |
| September 30, 2024 | -$0.18 | +14.3% | -5.9% |
| June 30, 2024 | -$0.17 | +22.7% | +15.0% |
| March 31, 2024 | -$0.20 | -17.6% | +4.8% |
| September 30, 2023 | -$0.21 | -61.5% | +4.5% |
| June 30, 2023 | -$0.22 | — | -29.4% |
- LEXICON PHARMACEUTICALS, INC. showed an increase of +77.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2017–2025 period, LEXICON PHARMACEUTICALS, INC.’s diluted eps has grown by 88.0% (from $1.17 per share (loss) to $0.14 per share (loss)).
- The most recent figure is from LEXICON PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: